What You Should Know:
- Canary Speech, Inc. (Canary), a pioneer in AI-powered voice biomarker technology, announced today it has closed a $13M Series A funding round.
- The round was led by Cortes Capital, LLC (Love’s Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health.
Canary's Cutting-Edge Technology
Canary Speech leverages vocal analysis to identify early signs of mental health and neurological conditions.
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Anterior Secures $20M to Streamline Healthcare Administration with GenAI
What You Should Know:
- Anterior, a healthcare administration platform built by clinicians raises $20M in Series A funding round.
- Led by New Enterprise Associates (NEA), the round included participation from Sequoia Capital, Blue Lion Global, and Neo. Formerly known as Co:Helm, Anterior recently rebranded to reflect its focus on moving healthcare administration forward.
Unburdening Clinicians with AI
Anterior's mission is to free doctors and nurses from the
Read More
Sware Secures $6M to Help Life Sciences Eliminate Validation Debt
What You Should Know
- Sware has secured $6 million in Series B funding to enhance its software validation solution for life sciences companies.
- The new funding will support research and development, AI-driven capabilities, and expansion of Sware's sales team to address validation debt.
Insights into Sware's Growth and Innovation
Sware, a leading provider of comprehensive software validation solutions for the life sciences industry, has announced a successful raise of $6 million in
Read More
Eko Health Raises $41M to Scale AI-driven Heart, Lung Detection
What You Should Know:
- Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million.
- This funding, led by ARTIS Ventures, Highland Capital Partners, NTTVC, and Questa Capital, will fuel Eko's mission to expand access to its innovative platform in the U.S. and globally.
Building on a Strong Foundation of Innovation and Clinical Validation
This funding round comes on the heels of
Read More
Nucleus RadioPharma Secures Investment from AstraZeneca
What You Should Know:
- Nucleus RadioPharma, the world's first comprehensive radiopharmaceutical organization, today announced the closing of an extended Series A funding round with the addition of new investor AstraZeneca.
- The strategic investment bolsters Nucleus' mission to make targeted radiotherapies and theranostics more accessible to patients worldwide.
AstraZeneca Joins Forces with Leading Radiopharmaceutical Innovator
AstraZeneca joins a distinguished group of
Read More
Sword Health Secures $130M, Unveils AI Care Specialist “Phoenix”
What You Should Know:
- Sword Health, a pioneer in AI-powered healthcare delivery, announced a $130M financing round today bringing Sword's total funding to $340M and propelling the company's valuation to a staggering $3B– a 50% increase since its Series D round.
- This funding round, coupled with Sword's near-tripled revenue growth in the past year, unlocks exciting possibilities for the future. The company plans to leverage these resources to revolutionize healthcare delivery and
Read More
Plenful Secures $17M to Scale AI-Powered Pharmacy Operations Tool
What You Should Know:
- Plenful, an AI workflow automation platform streamlining pharmacy and healthcare operations, today announced a $17M Series A round, increasing its total raised capital to more than $25 million.
- This milestone signifies a meaningful step forward in Plenful's mission to modernize pharmacy operations through
Read More
Weave Bio Launches for AI-Powered Drug Development, Secures $10M
What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
CVS + Echo Health Makes Strategic Investment in Thyme Care
What You Should Know:
- Thyme Care, a leader in value-based cancer care, has announced a strategic investment from Echo Health Ventures and CVS Health Ventures. Both partners have identified Thyme Care’s provider-centric approach as the only way to improve the patient experience and reduce costs across the care continuum. The investment was part of Thyme’s Series B fundraise.
- The strategic funding will fuel the national expansion of Thyme Care's innovative model, aiming to improve
Read More
Boulder Care Secures $35M to Expand Telehealth Addiction Treatment for Underserved Communities
What You Should Know:
- Boulder Care, a leading provider of high-quality addiction treatment, announced today the successful closing of an oversubscribed $35M Series C funding round led by Advance Venture Partners (AVP), joined by Stripes and existing investors, including First Round Capital, Qiming Venture Partners, and Laerdal Million Lives Fund.
- Boulder Care will invest in developing even more robust services tailored to address the specific needs of high-need patients and plans
Read More
